Predictive Value of HPV, p53, and p16 in the Post-Treatment Evolution of Malignant Tumors of the Oropharynx and Retromolar Trigone–Oropharynx Junction
Bogdan Mihail Cobzeanu(Grigore T. Popa University of Medicine and Pharmacy), Victor Vlad Costan(Grigore T. Popa University of Medicine and Pharmacy), Loredana Ungureanu(Iuliu Hațieganu University of Medicine and Pharmacy), Dragoș Octavian Palade(Grigore T. Popa University of Medicine and Pharmacy), Luiza Maria Cobzeanu(Grigore T. Popa University of Medicine and Pharmacy), Mihaela Moscalu(Center for Research and Interdisciplinarity), D. Negru(Grigore T. Popa University of Medicine and Pharmacy), Daniela Rusu(Grigore T. Popa University of Medicine and Pharmacy), Constantin Volovăț(Institutul Regional de Oncologie), Liliana Gheorghe(Virginia Commonwealth University), Mihail Dan Cobzeanu(Grigore T. Popa University of Medicine and Pharmacy), Luminiţa Rădulescu(Grigore T. Popa University of Medicine and Pharmacy), Daniela Matei(University of Medicine and Pharmacy of Craiova), Patricia Sonia Vonica(Grigore T. Popa University of Medicine and Pharmacy)
Cited by 3
Related Papers
Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
|Gastroenterology|2016|1k
Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial
|The Lancet Oncology|2013|838
<i>KRAS</i>,<i>NRAS</i>and<i>BRAF</i>mutations in Greek and Romanian patients with colorectal cancer: a cohort study
|BMJ Open|2014|43
The Gut Microbiome and Its Implication in the Mucosal Digestive Disorders
|Biomedicines|2022|31
<i>H</i><i>elicobacter pylori</i>infection and gastroesophageal reflux in children
|Diseases of the Esophagus|2015|29